Terms: = Leukemia AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Treatment
82 results:
1. Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia.
Albinger N; Müller S; Kostyra J; Kuska J; Mertlitz S; Penack O; Zhang C; Möker N; Ullrich E
Bone Marrow Transplant; 2024 Apr; 59(4):489-495. PubMed ID: 38253870
[TBL] [Abstract] [Full Text] [Related]
2. Distinct roles of hematopoietic cytokines in the regulation of leukemia stem cells in murine MLL-AF9 leukemia.
Li Y; Seet CS; Mack R; Joshi K; Runde AP; Hagen PA; Barton K; Breslin P; Kini A; Ji HL; Zhang J
Stem Cell Reports; 2024 Jan; 19(1):100-111. PubMed ID: 38101400
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Cell Type-Specific Effects of
Bae SG; Kim HJ; Kim MY; Kim DDH; Shin SI; Ahn JS; Park J
Mol Cells; 2023 Oct; 46(10):611-626. PubMed ID: 37853686
[TBL] [Abstract] [Full Text] [Related]
4. Cellular Composition and 5hmC Signature Predict the treatment Response of AML Patients to Azacitidine Combined with Chemotherapy.
Liang G; Wang L; You Q; Cahill K; Chen C; Zhang W; Fulton N; Stock W; Odenike O; He C; Han D
Adv Sci (Weinh); 2023 Aug; 10(23):e2300445. PubMed ID: 37271891
[TBL] [Abstract] [Full Text] [Related]
5. CRISPR/Cas9-Mediated Induction of Relapse-Specific
Nguyen TTT; Tanaka Y; Sanada M; Hosaka M; Tamai M; Kagami K; Komatsu C; Somazu S; Harama D; Kasai S; Watanabe A; Akahane K; Goi K; Inukai T
Mol Pharmacol; 2023 Apr; 103(4):199-210. PubMed ID: 36669880
[TBL] [Abstract] [Full Text] [Related]
6. Integrating RNA-seq and scRNA-seq to explore the biological significance of NAD + metabolism-related genes in the initial diagnosis and relapse of childhood B-cell acute lymphoblastic leukemia.
Lin C; Xu JQ; Zhong GC; Chen H; Xue HM; Yang M; Chen C
Front Immunol; 2022; 13():1043111. PubMed ID: 36439178
[TBL] [Abstract] [Full Text] [Related]
7. Glycolaldehyde-derived advanced glycation end products suppress STING/TBK1/IRF3 signaling via CD36.
Nishinaka T; Hatipoglu OF; Wake H; Watanabe M; Toyomura T; Mori S; Nishibori M; Takahashi H
Life Sci; 2022 Dec; 310():121116. PubMed ID: 36302498
[TBL] [Abstract] [Full Text] [Related]
8. 5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics.
Díaz-Santa J; Rodríguez-Romanos R; Coll R; Osca G; Pratcorona M; González-Bártulos M; Garrido A; Angona A; Talarn C; Tormo M; Arnan M; Vives S; Salamero O; Tuset E; Lloveras N; Díez I; Zamora L; Bargay J; Sampol A; Cruz D; Vila J; Sitges M; Garcia A; Vall-Llovera F; Esteve J; Sierra J; Gallardo D;
Eur J Haematol; 2022 Dec; 109(6):755-764. PubMed ID: 36063368
[TBL] [Abstract] [Full Text] [Related]
9. Pharmacologic Inhibition of nt5c2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic leukemia.
Reglero C; Dieck CL; Zask A; Forouhar F; Laurent AP; Lin WW; Albero R; Miller HI; Ma C; Gastier-Foster JM; Loh ML; Tong L; Stockwell BR; Palomero T; Ferrando AA
Cancer Discov; 2022 Nov; 12(11):2646-2665. PubMed ID: 35984649
[TBL] [Abstract] [Full Text] [Related]
10. A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia.
Zeng AGX; Bansal S; Jin L; Mitchell A; Chen WC; Abbas HA; Chan-Seng-Yue M; Voisin V; van Galen P; Tierens A; Cheok M; Preudhomme C; Dombret H; Daver N; Futreal PA; Minden MD; Kennedy JA; Wang JCY; Dick JE
Nat Med; 2022 Jun; 28(6):1212-1223. PubMed ID: 35618837
[TBL] [Abstract] [Full Text] [Related]
11. The Glycolytic Gatekeeper PDK1 defines different metabolic states between genetically distinct subtypes of human acute myeloid leukemia.
Erdem A; Marin S; Pereira-Martins DA; Cortés R; Cunningham A; Pruis MG; de Boer B; van den Heuvel FAJ; Geugien M; Wierenga ATJ; Brouwers-Vos AZ; Rego EM; Huls G; Cascante M; Schuringa JJ
Nat Commun; 2022 Mar; 13(1):1105. PubMed ID: 35232995
[TBL] [Abstract] [Full Text] [Related]
12. The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.
Mansur MB; Furness CL; Nakjang S; Enshaei A; Alpar D; Colman SM; Minto L; Irving J; Poole BV; Noronha EP; Savola S; Iqbal S; Gribben J; Pombo-de-Oliveira MS; Ford TM; Greaves MF; van Delft FW
Cancer Med; 2021 Jul; 10(14):4864-4873. PubMed ID: 34080325
[TBL] [Abstract] [Full Text] [Related]
13. Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect.
Janikashvili N; Gérard C; Thébault M; Brazdova A; Boibessot C; Cladière C; Ciudad M; Greigert H; Ouandji S; Ghesquière T; Samson M; Audia S; Saas P; Bonnotte B
Oncoimmunology; 2021 Feb; 10(1):1880046. PubMed ID: 33659098
[TBL] [Abstract] [Full Text] [Related]
14. Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations.
Antić Ž; Yu J; Van Reijmersdal SV; Van Dijk A; Dekker L; Segerink WH; Sonneveld E; Fiocco M; Pieters R; Hoogerbrugge PM; Van Leeuwen FN; Van Kessel AG; Waanders E; Kuiper RP
Haematologica; 2021 Dec; 106(12):3046-3055. PubMed ID: 33147938
[TBL] [Abstract] [Full Text] [Related]
15. Effects of nt5c2 Germline Variants on 6-Mecaptopurine Metabolism in Children With Acute Lymphoblastic leukemia.
Jiang C; Yang W; Moriyama T; Liu C; Smith C; Yang W; Qian M; Li Z; Tulstrup M; Schmiegelow K; Crews KR; Zhang H; Pui CH; Evans W; Relling M; Bhatia S; Yang JJ
Clin Pharmacol Ther; 2021 Jun; 109(6):1538-1545. PubMed ID: 33124053
[TBL] [Abstract] [Full Text] [Related]
16. Clinical Grade Production of Wilms' Tumor-1 Loaded Cord Blood-Derived Dendritic Cells to Prevent Relapse in Pediatric AML After Cord Blood Transplantation.
Plantinga M; Lo Presti V; de Haar CG; Dünnebach E; Madrigal A; Lindemans CA; Boelens JJ; Nierkens S
Front Immunol; 2020; 11():559152. PubMed ID: 33101274
[TBL] [Abstract] [Full Text] [Related]
17. Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia.
Han H; Byun JM; Shin DY; Yoon SS; Koh Y; Hong J; Kim I; Lee C; Yoo H; Yun H; Kim MJ; Cho SI; Seong MW; Park SS
Korean J Intern Med; 2021 Mar; 36(2):401-412. PubMed ID: 32811132
[TBL] [Abstract] [Full Text] [Related]
18. FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia.
Yu SL; Zhang H; Ho BC; Yu CH; Chang CC; Hsu YC; Ni YL; Lin KH; Jou ST; Lu MY; Chen SH; Wu KH; Wang SC; Chang HH; Pui CH; Yang JJ; Zhang J; Lin DT; Lin SW; Ma X; Yang YL
Sci Rep; 2020 Jul; 10(1):12074. PubMed ID: 32694622
[TBL] [Abstract] [Full Text] [Related]
19. Progress and Perspectives in the Development of Lentiviral Vector Producer Cells.
Ferreira MV; Cabral ET; Coroadinha AS
Biotechnol J; 2021 Jan; 16(1):e2000017. PubMed ID: 32686901
[TBL] [Abstract] [Full Text] [Related]
20. Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions.
Dong Z; Cheng WA; Smith DL; Huang B; Zhang T; Chang WC; Wang X; Forman SJ; Kwak LW; Qin H
Cancer Immunol Immunother; 2020 Oct; 69(10):2139-2145. PubMed ID: 32451682
[TBL] [Abstract] [Full Text] [Related]
[Next]
